Spasmolytic polypeptide is a major antral peptide: Distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach
- 1 October 1993
- journal article
- Published by Elsevier
- Vol. 105 (4) , 1110-1116
- https://doi.org/10.1016/0016-5085(93)90956-d
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in ‘gastric metaplasia’ of the proximal duodenum: Implications for the nature of ‘gastric metaplasia’The Journal of Pathology, 1993
- Proton NMR-based determination of the secondary structure of porcine pancreatic spasmolytic polypeptide: one of a new family of "trefoil" motif containing cell growth factorsBiochemistry, 1992
- pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine responseBritish Journal of Cancer, 1991
- Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tractGastroenterology, 1991
- Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissuesThe Journal of Pathology, 1990
- Complete Primary Structure of the Human Estrogen-Responsive Gene (pS2) Product1The Journal of Biochemistry, 1990
- Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cellsNature, 1990
- Breast Cancer-Associated pS2 Protein: Synthesis and Secretion by Normal Stomach MucosaScience, 1988
- Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7Nucleic Acids Research, 1984
- Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell lineNucleic Acids Research, 1982